Open dashboard
JNJNYSEPharmaceutical Preparations

Johnson & Johnson

$284.91-0.84 (-0.29%)Delayed price · Nov 16, 2026, 5:45 PM
⇄ Compare
Last report: 10-Q · Oct 21, 2026 ↗Latest period: Q3 2026 (Sep 27, 2026)Source: SEC EDGAR (XBRL)
Market cap

$685.87B

P/E (TTM)

42.6x

EV / EBIT

—

FCF yield

3.0%

Dividend yield

—

ROIC (10y avg.)

—

Revenue (TTM)

$99.34B

Net cash

-$27.42B

Price

Moat checklist

4/6

Simple tests over the last decade. A starting point, not a verdict.

  • –Average ROIC above 15%—
  • ✓Stable gross margin (range under 10 pts)4.7 pp
  • ✓Positive free cash flow every year10/10
  • ✕Revenue growing at least 5% a year3.0%
  • ✓Share count flat or shrinking-12.9%
  • ✓Debt below 3 years of free cash flow2.4x

Revenue, net income and free cash flow

Margins

Returns on capital

Diluted shares outstanding

Annual change in share count: -1.5%